UNSPSC 51333504: Ocaperidone

This classification denotes an antipsychotic agent with the molecular formula C24H25FN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 26HUS7139V, chemically known as 4h-pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2,9-dimethyl- but generally known as ocaperidone, which bears US NIH Compound Identifier 71351. European Medicines Agency schedules Ocaperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09395MIG.

UNSPSC 51333504 Ocaperidone is a Commodity code that nominally describes pharmaceutical products, but the recent state and local solicitation activity tagged to this code shows a mismatch: Seminole County, Florida posted an IFB for naloxone and drug deactivation systems rather than ocaperidone itself. The procurement solicits 1,900 units of naloxone and 800 safe drug deactivation systems annually to support community health initiatives, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors must submit bids electronically through the county's e-Procurement Portal, include all shipping and delivery costs in their proposal, provide unit costs for each line item, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary period during which the county can terminate with or without cause.

Seminole County, Florida, appears as the only identified recent buyer under this code. The naloxone and drug deactivation systems procurement (IFB 60459723LAS) posted June 30, 2026, with a response deadline of July 26, 2026, at 2:00 pm. The procurement may draw FEMA funding and requires vendors to comply with federal environmental regulations including the Clean Air Act and Federal Water Pollution Control Act. Given the single recent opportunity and the disconnect between the code's nominal pharmaceutical scope and the actual community health product being solicited, this code shows limited recent activity in state and local procurement.